Filed: 5/15/2025ACC: 0001583977-25-000005
📋 What this filing means
CORMORANT ASSET MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 42 equity positions with a total reported market value of $1.33B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
42
Positions
$1.33B
Total AUM (reported)
77.35M
Total Shares
Allocation by class
COM$551.95M41.5%
CLASS A ORD$331.87M25.0%
COM NEW$165.48M12.4%
ORDINARY SHARES$85.11M6.4%
COMMON STOCK$68.88M5.2%
SPONSORED ADS$45.83M3.4%
COM PAR $.01$40.05M3.0%
Portfolio Concentration
Top 3$491.25M36.9%
4–10$379.34M28.5%
11–25$341.54M25.7%
Rest$117.82M8.9%
Top 3 weight
36.9%
Top 10 weight
65.5%
Voting Authority Distribution
Total shares with voting rights: 77.35M
Sole
Full voting authority
77.35M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other42
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings42
Rows:
MOONLAKE IMMUNOTHERAPEUTICS
DFNDShares8.49M
TypeSH
Market value$331.87M
24.95%
Sole
8.49M
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
DFNDShares4.10M
TypeSH
Market value$90.24M
6.79%
Sole
4.10M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
DFNDShares2M
TypeSH
Market value$69.14M
5.20%
Sole
2M
Shared
0.00
None
0.00
ARCELLX INC
DFNDShares1.05M
TypeSH
Market value$68.88M
5.18%
Sole
1.05M
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
DFNDShares1.75M
TypeSH
Market value$66.08M
4.97%
Sole
1.75M
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA COMPANY
DFNDShares3.08M
TypeSH
Market value$62.95M
4.73%
Sole
3.08M
Shared
0.00
None
0.00
JANUX THERAPEUTICS INC
DFNDShares2.15M
TypeSH
Market value$58.05M
4.36%
Sole
2.15M
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
DFNDShares8.32M
TypeSH
Market value$45.12M
3.39%
Sole
8.32M
Shared
0.00
None
0.00
INSMED INC
DFNDShares525K
TypeSH
Market value$40.05M
3.01%
Sole
525K
Shared
0.00
None
0.00
BRIGHT MINDS BIOSCIENCES INC
DFNDShares1.06M
TypeSH
Market value$38.21M
2.87%
Sole
1.06M
Shared
0.00
None
0.00
HELIX ACQUISITION CORP II
DFNDShares2.91M
TypeSH
Market value$32.87M
2.47%
Sole
2.91M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
DFNDShares2.26M
TypeSH
Market value$32.52M
2.45%
Sole
2.26M
Shared
0.00
None
0.00
MERUS N V
DFNDShares740K
TypeSH
Market value$31.15M
2.34%
Sole
740K
Shared
0.00
None
0.00
RAPPORT THERAPEUTICS INC
DFNDShares2.94M
TypeSH
Market value$29.50M
2.22%
Sole
2.94M
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
DFNDShares250K
TypeSH
Market value$29.16M
2.19%
Sole
250K
Shared
0.00
None
0.00
PHARVARIS N V
DFNDShares1.47M
TypeSH
Market value$23.02M
1.73%
Sole
1.47M
Shared
0.00
None
0.00
GH RESEARCH PLC
DFNDShares2.01M
TypeSH
Market value$22.16M
1.67%
Sole
2.01M
Shared
0.00
None
0.00
ARCUTIS BIOTHERAPEUTICS INC
DFNDShares1.35M
TypeSH
Market value$21.11M
1.59%
Sole
1.35M
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS INC
DFNDShares400K
TypeSH
Market value$20.55M
1.55%
Sole
400K
Shared
0.00
None
0.00
ARS PHARMACEUTICALS INC
DFNDShares1.60M
TypeSH
Market value$20.13M
1.51%
Sole
1.60M
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
DFNDShares600K
TypeSH
Market value$20.12M
1.51%
Sole
600K
Shared
0.00
None
0.00
CG ONCOLOGY INC
DFNDShares775K
TypeSH
Market value$18.98M
1.43%
Sole
775K
Shared
0.00
None
0.00
CARGO THERAPEUTICS INC
DFNDShares3.38M
TypeSH
Market value$13.76M
1.03%
Sole
3.38M
Shared
0.00
None
0.00
ABIVAX SA
DFNDShares2.13M
TypeSH
Market value$13.31M
1.00%
Sole
2.13M
Shared
0.00
None
0.00
ALUMIS INC
DFNDShares2.15M
TypeSH
Market value$13.19M
0.99%
Sole
2.15M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MOONLAKE IMMUNOTHERAPEUTICSDFND | CLASS A ORD | 8.49M | SH | $331.87M 24.95% | 8.49M | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCDFND | COM | 4.10M | SH | $90.24M 6.79% | 4.10M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCDFND | COM | 2M | SH | $69.14M 5.20% | 2M | 0.00 | 0.00 |
ARCELLX INCDFND | COMMON STOCK | 1.05M | SH | $68.88M 5.18% | 1.05M | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES IDFND | COM NEW | 1.75M | SH | $66.08M 4.97% | 1.75M | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA COMPANYDFND | ORDINARY SHARES | 3.08M | SH | $62.95M 4.73% | 3.08M | 0.00 | 0.00 |
JANUX THERAPEUTICS INCDFND | COM | 2.15M | SH | $58.05M 4.36% | 2.15M | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCDFND | COM NEW | 8.32M | SH | $45.12M 3.39% | 8.32M | 0.00 | 0.00 |
INSMED INCDFND | COM PAR $.01 | 525K | SH | $40.05M 3.01% | 525K | 0.00 | 0.00 |
BRIGHT MINDS BIOSCIENCES INCDFND | COM NEW | 1.06M | SH | $38.21M 2.87% | 1.06M | 0.00 | 0.00 |
HELIX ACQUISITION CORP IIDFND | CL A ORD SHS | 2.91M | SH | $32.87M 2.47% | 2.91M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCDFND | SPONSORED ADS | 2.26M | SH | $32.52M 2.45% | 2.26M | 0.00 | 0.00 |
MERUS N VDFND | COM | 740K | SH | $31.15M 2.34% | 740K | 0.00 | 0.00 |
RAPPORT THERAPEUTICS INCDFND | COM | 2.94M | SH | $29.50M 2.22% | 2.94M | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCDFND | COM | 250K | SH | $29.16M 2.19% | 250K | 0.00 | 0.00 |
PHARVARIS N VDFND | COM | 1.47M | SH | $23.02M 1.73% | 1.47M | 0.00 | 0.00 |
GH RESEARCH PLCDFND | ORDINARY SHARES | 2.01M | SH | $22.16M 1.67% | 2.01M | 0.00 | 0.00 |
ARCUTIS BIOTHERAPEUTICS INCDFND | COM | 1.35M | SH | $21.11M 1.59% | 1.35M | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS INCDFND | COM | 400K | SH | $20.55M 1.55% | 400K | 0.00 | 0.00 |
ARS PHARMACEUTICALS INCDFND | COM | 1.60M | SH | $20.13M 1.51% | 1.60M | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INDFND | COM | 600K | SH | $20.12M 1.51% | 600K | 0.00 | 0.00 |
CG ONCOLOGY INCDFND | COM | 775K | SH | $18.98M 1.43% | 775K | 0.00 | 0.00 |
CARGO THERAPEUTICS INCDFND | COM | 3.38M | SH | $13.76M 1.03% | 3.38M | 0.00 | 0.00 |
ABIVAX SADFND | SPONSORED ADS | 2.13M | SH | $13.31M 1.00% | 2.13M | 0.00 | 0.00 |
ALUMIS INCDFND | COM | 2.15M | SH | $13.19M 0.99% | 2.15M | 0.00 | 0.00 |
Page 1 of 2